SCHEMBL19851025

SCHEMBL19851025

CCOC(=O)C(C)Sc1nc2cccnc2n1-c1c(C)cc(C)cc1C

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.50
ATM Q13315 1/20 0.50
LMNA P02545 3/20 0.48
ALDH1A1 P00352 6/20 0.43
PLA2G1B P04054 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
ALOX15 P16050 2/20 0.43
POLB P06746 2/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPT P10636 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
RECQL P46063 1/20 0.43
MAPK1 P28482 5/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
PABPC1 P11940 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19851012 0.88 PTGS2 (0.44) TSHRLMNAALDH1A1NPSR1POLB
SCHEMBL19851099 0.83 TSHR (0.68) TSHRATMLMNAALDH1A1ALOX15
SCHEMBL23954450 0.83 MAPT (0.40) TSHRLMNAALDH1A1POLBMAPT
SCHEMBL19851010 0.82 LMNA (0.47) TSHRATMLMNAALDH1A1ALOX15
SCHEMBL19851021 0.80 TSHR (0.54) TSHRATMLMNAALDH1A1ALOX15
SCHEMBL19851096 0.80 TSHR (0.56) TSHRATMLMNAALDH1A1PLA2G1B
SCHEMBL21093721 0.79 TSHR (0.47) TSHRLMNAALDH1A1POLBMAPT
SCHEMBL19851019 0.78 ALDH1A1 (0.51) TSHRLMNAALDH1A1ALOX15POLB
SCHEMBL19851013 0.75 SLC22A12 (0.50) TSHRLMNAALDH1A1POLBMAPT
SCHEMBL19851011 0.75 MAPT (0.45) TSHRLMNAALDH1A1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495362-B1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF UNIV SHANDONG (CN) 2021-10-27 EP disclosed
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SHANDONG UNIVERSITY (CN) 2019-09-03 US disclosed
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SHANDONG UNIVERSITY (CN) 2019-07-25 US disclosed
EP-3495362-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shandong University (CN) 2019-06-12 EP disclosed
WO-2018023851-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 山东大学 2018-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SLC29A1, SLC28A1, SLC5A1 TSHR 2731/4885ATM 4793/4885LMNA 4231/4885
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SLC29A1, SLC28A1, SLC5A1 TSHR 2444/4885ATM 4747/4885LMNA 3991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.